Drug Approval | July 24, 2024
Gland Pharma receives USFDA’s tentative approval for Latanoprostene Bunod Ophthalmic Solution
The product is bioequivalent and therapeutically equivalent to the reference listed drug
The product is bioequivalent and therapeutically equivalent to the reference listed drug
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
A significant proportion of healthcare professionals still tend to favor branded drugs
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Distributes Ayushman cards to several beneficiaries
The company has entered into a three-year Deferred Prosecution Agreement
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Subscribe To Our Newsletter & Stay Updated
